<?xml version="1.0"?>
<Articles JournalTitle="Acta Medica Iranica">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>64</Volume>
      <Issue>8</Issue>
      <PubDate PubStatus="epublish">
        <Year>2026</Year>
        <Month>07</Month>
        <Day>12</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Comparison of Cutaneous Leishmaniasis Patients in One-Year Pre-Outbreak and One-Year Post-Outbreak of COVID-19 in Shiraz City, Iran</title>
    <FirstPage>477</FirstPage>
    <LastPage>481</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Narjes</FirstName>
        <LastName>Yektaeian</LastName>
        <affiliation locale="en_US">Department of Parasitology and Mycology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Ali Abbas</FirstName>
        <LastName>Saheli</LastName>
        <affiliation locale="en_US">Department of Parasitology and Mycology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Majid</FirstName>
        <LastName>Dousti</LastName>
        <affiliation locale="en_US">Department of Parasitology and Mycology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Vahid</FirstName>
        <LastName>&#x136;hatamifar</LastName>
        <affiliation locale="en_US">Vice Chancellor for Health, Shiraz University of Medical Sciences, Shiraz, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Manouchehr</FirstName>
        <LastName>Shirani</LastName>
        <affiliation locale="en_US">1 Department of Parasitology and Mycology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Gholamreza</FirstName>
        <LastName>Hatam</LastName>
        <affiliation locale="en_US">Basic Sciences in Infectious Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2024</Year>
        <Month>11</Month>
        <Day>06</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2025</Year>
        <Month>12</Month>
        <Day>07</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Iran ranks among the top ten countries for leishmaniasis and COVID-19 outbreaks. This study compared cutaneous leishmaniasis (CL) cases in Shiraz one year before and one year after the COVID-19 outbreak. In this study, the recorded information of 988 suspected cutaneous leishmaniasis (CL) patients referred to Valfajr Health Center was meticulously collected, prepared, and analyzed using the SPSS-24 Software and the Chi-square test. Comparing the pre-outbreak period (February 2019-March 2020) to the post-outbreak period (March 2021), 57.9% of 526 suspected CL cases were positive before the outbreak versus 76.4% of 462 cases after the outbreak. Pre-outbreak, women constituted 53.8% of CL cases, whereas post-outbreak, men constituted 55.8% of cases. The presence of underlying conditions, notably diabetes and hypertension, increased 3.5 times after the COVID-19 outbreak. Employment status also shifted, with increases in employed (from 5.3% to 10.5%) and self-employed (from 44.4% to 47.7%) individuals and a decrease in housewives (from 48.3% to 37.6%). COVID-19 has significantly impacted CL parameters, particularly gender distribution, employment status, and the acute-chronic nature of the disease, due to increased economic activity and community presence.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/11347</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/11347/6082</pdf_url>
  </Article>
</Articles>
